Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-07-02

Clinical Trial Update: A Clinical Study Investigating the Therapeutic Effects and Safety of an Investigational Cell Therapy Given With and Without an Additional Investigational Product in Males With Testicular Cancer or a Form of Cancer That Developed From Sperm [Phase 2]

View source ↗

Summary

Phase 2 trial of an investigational cell therapy given with and without an additional investigational product for male patients with testicular germ cell tumors…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Investigational cell therapy

Snippet

Sponsor: BioNTech SE | Conditions: Testicular Germ Cell Tumor, Extragonadal Germ Cell Tumor | Phase 2 | Status: WITHDRAWN